European Testosterone Replacement Therapies Markets

Published by: Frost & Sullivan

Published: Aug. 7, 2007 - 76 Pages

Table of Contents

1. Executive Summary

1. Executive Summary of the European Testosterone Replacement Therapies Market

1. Executive Summary

2. Research Methodology

1. Research Scope and Segmentation

1. Methodology

3. Industry Challenges

1. Challenges Facing the European Testosterone Replacement Therapies Market

1. Industry Challenges

4. European Testosterone Replacement Therapies Market Outlook

1. Hypogonadism

1. Description of the Condition

2. Epidemiology

3. Current Treatment Options

5. Market Engineering Research for the European Testosterone Replacement Therapies Market

1. Market Engineering Research

1. Market Overview

2. Market Engineering Measurements

3. Market Drivers

a. Product Launches Increase Awareness, Competition and Market Growth

b. Increasing Consciousness over Improved Quality of Life

c. Ageing Male Population Increases Target Population Size

4. Market Restraints

a. Direct-to-consumer Pharmaceutical Advertising (DTCA) Not Allowed in Europe

b. Poor Reimbursement for Therapies

c. Low Patient-to-doctor Ratio

5. Revenue Forecasts

6. Trends by Segment

7. End-user Analysis

8. Competitive Landscape

6. Competitor Analysis

1. Portfolio Analysis

1. Bayer Schering Pharma AG

2. Ipsen

3. GlaxoSmithKline

4. Ardana Plc

5. Organon

6. ProStrakan Group Plc

7. Strategic Recommendations for the European Testosterone Replacement Therapies Market

1. Strategic Recommendations

1. Market Engineering Recommendations

8. Database of Key Industry Participants

1. Key Industry Participants

1. Major Participants

9. Appendix

1. Decision Support Database

1. Male Population

2. Male Population Over 65 Years

3. Number of Physicians

4. Prevalence of Obese Population Over 15 Years of Age

5. Prostrate Cancer Incidence

List of Figures

Chapter 3

Testosterone Replacement Therapies Market: Impact of Top Industry Challenges (Europe), 2007-2013

Chapter 4

Testosterone Replacement Therapies Market: Treatment Algorithms by Country (Europe), 2006

Testosterone Replacement Therapies Market: Prevalence of Male Hypogonadism by Age Group (Europe), 2006

Testosterone Replacement Therapies Market: Unmet Needs (Europe), 2006

Chapter 5

Testosterone Replacement Therapies Market: Market Drivers Ranked in Order of Impact (Europe), 2007-2013

Testosterone Replacement Therapies Market: Market Restraints Ranked in Order of Impact (Europe), 2007-2013

Testosterone Replacement Therapies Market: Per cent of Revenues by Product Type (Europe), 2003-2013

Testosterone Replacement Therapies Market: Revenue Forecasts for the Gels Segment (Europe), 2003-2013

Testosterone Replacement Therapies Market: Revenue Forecasts for the Injections Segment (Europe), 2003-2013

Testosterone Replacement Therapies Market: Revenue Forecasts for the Patches Segment (Europe), 2003-2013

Testosterone Replacement Therapies Market: Revenue Forecasts for the Orals Segment (Europe), 2003-2013

Testosterone Replacement Therapies Market: Revenue Forecasts for the Buccals Segment (Europe), 2003-2013

Testosterone Replacement Therapies Market: Revenue Forecasts for the Pellets Segment (Europe), 2003-2013

Testosterone Replacement Therapies Market: Total Revenue Forecasts (Europe), 2003-2013

Testosterone Replacement Therapies Market: Market Share by Product Segments (Europe), 2006

Testosterone Replacement Therapies Market: Competitive Structure (Europe), 2006

Chapter 7

Testosterone Replacement Therapies Market: Strategic Recommendations (Europe), 2007-2013

Chapter 9

Decision Support Database: Male Population in Million (World), 2002-2012

Decision Support Database: Male Population 65 Plus in Million (World), 2002-2012

Decision Support Database: Number of Physicians in '000 (World), 2002-2012

Decision Support Database: Prevalence of Obese Population Over 15 years in Million (World), 2002-2012

Decision Support Database: Prostate Cancer Incidence in '000 (World), 2002-2012

Abstract

Research Overview

This Frost & Sullivan research service on the European Testosterone Replacement Therapies Market provides an overview of current treatment options, detailed analysis of the market, technological advancements and revenues of the market along with a complete analysis of key market drivers, restraints and trends prevailing in the European market. In this research, Frost & Sullivan's expert analysts thoroughly examine the following markets: transdermal gels, intramuscular injections, patches, orals, buccals and pellets.

Market Sectors

Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this research:

• Transdermal gels
• Intramuscular injections
• Patches
• Orals
• Buccals
• Pellets

Market Overview

Campaigns to Overcome Low Awareness and Expand Target Population

The market for testosterone replacement therapies is still very young, though such therapies have been in existence for decades. There are a number of reasons for this slow uptake, including low awareness levels among patients and the medical community as well as poor adherence to diagnosis standards. Male hypogonadism is a condition that affects the quality of life of males, especially in the later stages of their lives. Symptoms of this condition are caused by reduced levels of the serum testosterone and are, therefore, treated with testosterone substitution through various formulations. However, late-onset-hypogonadism among older males is not recognised as a condition that needs focused diagnosis and treatment. This situation has resulted in an undersized target demographic, as older males constitute a major proportion of the population suffering from hypogonadism.

The market is at a nascent stage and there is considerable scope for expansion. However, both existing and prospective market participants face a significant obstacle in the form of an undersized target population. "Promisingly, the market has started to display signs of increasing growth mainly due to the aggressive marketing campaigns of market participants," notes the analyst of this research. "Growth rates are expected to rise in the next two to three years owing to an expansion of the target population."

Product Differentiation and Efficacy Keys to Success

Primarily, the gels and injections segments drive the market. Gels are gradually displacing alternative treatment modes that have proven less effective. They are also challenging the dominance of injections, which have been the preferred mode of treatment for almost a decade. "With patient acceptability and efficacy playing vital roles in the success of a product in this industry, gels and injections will continue to propel the industry unless a better formulation is introduced," says the analyst.

Market participants should concentrate on achieving product differentiation; high-quality products supported by aggressive marketing campaigns will make a definite impact on the market. The willingness to investigate untapped markets will also be vital to gain the competitive edge since first-mover advantage will provide a strong platform for future growth.

Get Full Details About This Report >>

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.